FIG. 4.

shows the percent of all participants collapsed across PN and PN+CM (N = 508 due to missing viral load data) with suppressed viral load (≤200 copies/mL) at the 6-month assessment as a function of HIV care visits attended (top panel) and number of validated medication checks (bottom panel). Sample sizes for HIV care visits are 0 (N = 90), 1–2 (N = 180), and 3–4 (N = 238). Sample sizes for validated medication check categories are 0–1 (N = 188), 2–3 (N = 103), 4–5 (N = 95), and 6–7 (N = 122). Data for PN and PN+CM groups separately are shown in Tables 2 and 3.